Loading...
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
The IL-17/IL-23 axis is now understood to influence psoriasis, and the development of novel IL-17 inhibitor medications marks a sea change in the treatment of psoriasis. Brodalumab is a recombinant, fully human immunoglobulin IgG2 monoclonal antibody specifically targeted against IL-17RA. This artic...
Na minha lista:
| Udgivet i: | Clin Cosmet Investig Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503649/ https://ncbi.nlm.nih.gov/pubmed/31118733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S165605 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|